Recently, a preclinical study (Yun et al., 2015) reported that cancer cell-selective toxicity of AA in colorectal cancer with KRAS and BRAF mutation could be enhanced by induction of GLUT-mediated cellular uptake of DHA. This evidence concerns the gene KRAS and colorectal cancer.